20/20 BIOLABS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
20/20 BIOLABS, INC. (AIDX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -2.90% for the 12-month period ending 2025-12-31, per its POS AM filed 2026-04-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-04-06
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2025-12-31 | -2.90% POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |